Cargando…

AGO Austria recommendations for genetic testing of patients with ovarian cancer

In Austria, 700 women are diagnosed every year with ovarian carcinoma. Approximately 15 % of the patients with epithelial ovarian cancer have a germline mutation in the BRCA1 or BRCA2 genes. The increased incidence of breast and/or ovarian cancer in genetically related family members has given rise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marth, Christian, Hubalek, Michael, Petru, Edgar, Polterauer, Stephan, Reinthaller, Alexander, Schauer, Christian, Scholl-Firon, Tonja, Singer, Christian F., Zschocke, Johannes, Zeimet, Alain G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2015
Materias:	Position Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536270/ https://www.ncbi.nlm.nih.gov/pubmed/26109557 http://dx.doi.org/10.1007/s00508-015-0814-7

Ejemplares similares

AGO Austria recommendation on screening and diagnosis of Lynch syndrome (LS)
por: Zeimet, Alain G., et al.
Publicado: (2017)

Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer
por: Tsibulak, Irina, et al.
Publicado: (2022)

Axillary lymph node status and invasive lobular breast cancer: Analysis of the Clinical Tumor Register of the AGO Austria
por: Danzinger, Sabine, et al.
Publicado: (2023)

Joint Guideline of the OEGGG, AGO, AGK and ÖGZ on the Diagnosis and Treatment of Cervical Intraepithelial Neoplasia and Appropriate Procedures When Cytological Specimens Are Unsatisfactory
por: Reich, Olaf, et al.
Publicado: (2018)

French recommendations for the management of systemic sclerosis
por: Hachulla, Eric, et al.
Publicado: (2021)

Optimising the diagnosis and referral of achondroplasia in Europe: European Achondroplasia Forum best practice recommendations
por: Cormier-Daire, Valerie, et al.
Publicado: (2022)

Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies: Position paper of the Heart Failure Working Group of the Austrian Society of Cardiology
por: Bergler-Klein, Jutta, et al.
Publicado: (2022)

Clinical Impact of RANK Signalling in Ovarian Cancer
por: Wieser, Verena, et al.
Publicado: (2019)

Efficacy of an optimal ovarian cancer screening: a best-case scenario study based on real-world data
por: Steinkasserer, Lena, et al.
Publicado: (2021)

Prognostic role of plasma fibrinogen in patients with uterine leiomyosarcoma – a multicenter study
por: Bekos, Christine, et al.
Publicado: (2017)

French recommendations for the management of Behçet’s disease
por: Kone-Paut, Isabelle, et al.
Publicado: (2021)

French recommendations for the management of Takayasu’s arteritis
por: Saadoun, David, et al.
Publicado: (2021)

Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer
por: Leitner, Katharina, et al.
Publicado: (2020)

Summary of Revisions for the 2012 Clinical Practice Recommendations
Publicado: (2012)

Nutrition Therapy Recommendations for the Management of Adults With Diabetes
por: Evert, Alison B., et al.
Publicado: (2013)

Recommendations for the design of small population clinical trials
por: Day, Simon, et al.
Publicado: (2018)

Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma
por: Schwameis, Richard, et al.
Publicado: (2016)

Enlarged cardiophrenic lymph nodes predict disease involvement of the upper abdomen and the outcome of primary surgical debulking in advanced ovarian cancer
por: Luger, Anna K., et al.
Publicado: (2020)

Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III
por: Ghosh, Arunabha, et al.
Publicado: (2017)

Rare diseases in Chile: challenges and recommendations in universal health coverage context
por: Encina, Gonzalo, et al.
Publicado: (2019)

UK recommendations for SDHA germline genetic testing and surveillance in clinical practice
por: Hanson, Helen, et al.
Publicado: (2023)

Diagnostic and therapeutic recommendations for the treatment of hyperphenylalaninemia in patients 0–4 years of age
por: Muntau, Ania C., et al.
Publicado: (2018)

Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer
por: Azim, Samira Abdel, et al.
Publicado: (2016)

French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)
por: Terrier, Benjamin, et al.
Publicado: (2020)

Treatment of relapsing multiple sclerosis in Hungary – consensus recommendation from the Hungarian neuroimmunology society
por: Rajda, Cecilia, et al.
Publicado: (2023)

Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
por: Teede, Helena J, et al.
Publicado: (2023)

Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers
por: Notaro, Sara, et al.
Publicado: (2016)

The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer – A Retrospective Study
por: Seebacher, Veronika, et al.
Publicado: (2017)

HCV Council – critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape
por: Reau, Nancy, et al.
Publicado: (2015)

Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL)
por: Annemans, Lieven, et al.
Publicado: (2017)

Combining evidence for and against pathogenicity for variants in cancer susceptibility genes: CanVIG-UK consensus recommendations
por: Garrett, Alice, et al.
Publicado: (2021)

Patient care standards for primary mitochondrial disease in Australia: an Australian adaptation of the Mitochondrial Medicine Society recommendations
por: Sue, Carolyn M., et al.
Publicado: (2021)

Tumor necrosis factor receptor modulator spermatogenesis‐associated protein 2 is a novel predictor of outcome in ovarian cancer
por: Wieser, Verena, et al.
Publicado: (2019)

A comparison of four technologies for detecting p53 aggregates in ovarian cancer
por: Heinzl, Nicole, et al.
Publicado: (2022)

Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia
por: Agarwal, M. B., et al.
Publicado: (2015)

Recommendations from the IRDiRC Working Group on methodologies to assess the impact of diagnoses and therapies on rare disease patients
por: Zanello, Galliano, et al.
Publicado: (2022)

Ageing well with diabetes: A workshop to co‐design research recommendations for improving the diabetes care of older people
por: Wylie, Thomas A. F., et al.
Publicado: (2022)

Towards the international interoperability of clinical research networks for rare diseases: recommendations from the IRDiRC Task Force
por: Nabbout, Rima, et al.
Publicado: (2023)

Emergency management of patients with Glanzmann thrombasthenia: consensus recommendations from the French reference center for inherited platelet disorders
por: Fiore, Mathieu, et al.
Publicado: (2023)

Current status of allergy prevalence in Germany: Position paper of the Environmental Medicine Commission of the Robert Koch Institute
por: Bergmann, Karl-Christian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p0a8ggsut02pspq2tb196dsf33